CC-96191

· Celgene

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CC-96191, covering 2025-05-31 to 2025-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]